( April 21, 2025, 2:05 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on April 21 granted the Food and Drug Administration’s petition for a writ of certiorari challenging the Fifth Circuit U.S. Court of Appeals’ reversal of FDA bans of several flavored e-liquid products, vacated the ruling and remanded the case to the Fifth Circuit for consideration of its recent vacatur of the en banc Fifth Circuit in Food and Drug Administration v. Wages & White Lion and denied three other petitions for review filed by vape companies challenging FDA bans....